Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Nature Medicine

• Publication date

  1998-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/NM0898-923PMID 9701244
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma

  2004cited by this paper
• Impaired arterial neointima formation in mice with disruption of the plasminogen gene.

  1997cited by this paper
• The urokinase‐type plasminogen activator system in cancer metastasis: A review

  1997cited by this paper
• Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration.

  1997cited by this paper
• Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice.

  1997cited by this paper
• Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin.

  1997cited by this paper
• Halting angiogenesis suppresses carcinoma cell invasion

  1997cited by this paper
• The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin.

  1996cited by this paper
• Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?

  1996cited by this paper
• The urokinase receptor is a major vitronectin-binding protein on endothelial cells.

  1996cited by this paper
• The serpin PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectin

  1996cited by this paper
• In situ analysis of changes in telomere size during replicative aging and cell transformation

  1996cited by this paper
• Immunohistochemical localization of the plasminogen activator inhibitor‐1 in breast cancer

  1995cited by this paper
• Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.

  1995cited by this paper
• Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system.

  1995cited by this paper
• Immunoassay of Murine t-PA, u-PA and PAI-1 Using Monoclonal Antibodies Raised in Gene-inactivated Mice

  1995cited by this paper
• Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways

  1995cited by this paper
• Co‐expression of urokinase, urokinase receptor and PAI‐1 is necessary for optimum invasiveness of cultured lung cancer cells

  1995cited by this paper
• Biological Effects of Combined Inactivation of Plasminogen Activator and Plasminogen Activator Inhibitor-1 Gene Function in Mice

  1995cited by this paper
• The Keratinocyte handbook

  1994cited by this paper
• Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy.

  1994cited by this paper
• Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue.

  1994cited by this paper
• Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer.

  1994cited by this paper
• Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis.

  1994cited by this paper
• Plasminogen activator inhibitor-1 and prognosis in primary breast cancer.

  1994cited by this paper
• Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization.

  1993cited by this paper
• Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.

  1993cited by this paper
• Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasiveness

  1993cited by this paper
• High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis.

  1993cited by this paper
• Biology and biochemistry of proteinases in tumor invasion.

  1993cited by this paper
• Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues.

  1992cited by this paper
• The role of plasminogen activators in the regulation of connective tissue metalloproteinases.

  1992cited by this paper
• In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis.

  1992cited by this paper
• The Role of Plasmhogen Activators in the Regulation of Connective Tissue Metalloproteinases a

  1992cited by this paper
• Plasminogen activator inhibitor‐1 is induced in migrating endothelial cells

  1992cited by this paper
• Differential protease expression by cutaneous squamous and basal cell carcinomas.

  1991cited by this paper
• The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma.

  1991cited by this paper
• Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract

  1991cited by this paper
• Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse.

  1991cited by this paper
• The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1

  1990cited by this paper
• Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes.

  1990cited by this paper
• Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene.

  1990cited by this paper
• c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy.

  1990cited by this paper
• Plasminogen Activator Inhibitor 1 and Plasminogen Activator Inhibitor 2 in Various Disease States

  1988cited by this paper
• Characteristics of chemically transformed mouse epidermal cells in vitro and in vivo.

  1978cited by this paper
• A Review of the

  year unknowncited by this paper

• Novel Hyperplastic Expansion of White Adipose Tissue Underlies the Metabolically Healthy Obese Phenotype of Male LFABP Null Mice

  2025cites this paper
• Semi-synthetic fibrous fibrin composites promote 3D microvascular assembly, survival, and host integration of endothelial cells without mesenchymal cell support

  2025cites this paper
• Clinical Efficacy of Ex Vivo Cross-Linking on Neovascularization of the Donor Cornea Carrier Tissue for the Boston Type I Keratoprosthesis

  2025cites this paper
• Exosomes in Skin Flap Survival: Unlocking Their Role in Angiogenesis and Tissue Regeneration

  2025cites this paper
• SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment

  2024cites this paper
• Unconventional localization of PAI-1 in PML bodies: A possible link with cellular growth of endothelial cells

  2024cites this paper
• Suppressing Expression of SERPINE1/PAI1 Through Activation of GPER1 Reduces Progression of Vulvar Carcinoma

  2024cites this paper
• Targeting aging and age-related diseases with vaccines

  2024cites this paper
• Ketosis Suppression and Ageing (KetoSAge): The Effects of Suppressing Ketosis in Long Term Keto-Adapted Non-Athletic Females

  2023cites this paper
• Identification and validation of a T cell marker gene-based signature to predict prognosis and immunotherapy response in gastric cancer

  2023cites this paper
• Identification and validation of SERPINE1 as a prognostic and immunological biomarker in pan-cancer and in ccRCC

  2023cites this paper
• The 14-Kilodalton Human Growth Hormone Fragment a Potent Inhibitor of Angiogenesis and Tumor Metastasis

  2023cites this paper
• Continuous administration of anti-VEGFA antibody upregulates PAI-1 secretion from ovarian cancer cells via miR-143-3p downregulation.

  2023cites this paper
• Cancer-associated fibroblast-derived PAI-1 promotes lymphatic metastasis via the induction of EndoMT in lymphatic endothelial cells

  2023cites this paper
• Does Opium Consumption Have Shared Impact on Atherosclerotic Cardiovascular Disease and Cancer?

  2022cites this paper
• The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer

  2022cites this paper
• Biomarkers for anti-vascular endothelial growth factor drugs

  2022cites this paper
• Plasmin and Plasminogen System in the Tumor Microenvironment: Implications for Cancer Diagnosis, Prognosis, and Therapy

  2021cites this paper
• High SPINK4 Expression Predicts Poor Outcomes among Rectal Cancer Patients Receiving CCRT

  2021cites this paper
• The relevance of Chemistry in Tumor microenvironment of Cancer Patient

  2021cites this paper
• Immunoreactivity of Plasminogen Activator Inhibitor 1 and Its Correlation with Dysmenorrhea and Lesional Fibrosis in Adenomyosis

  2021cites this paper
• The Plasminogen–Activator Plasmin System in Physiological and Pathophysiological Angiogenesis

  2021cites this paper
• LncRNA NKX2‐1‐AS1 promotes tumor progression and angiogenesis via upregulation of SERPINE1 expression and activation of the VEGFR‐2 signaling pathway in gastric cancer

  2021cites this paper
• Targeting Intercellular Communication in the Bone Microenvironment to Prevent Disseminated Tumor Cell Escape from Dormancy and Bone Metastatic Tumor Growth

  2021cites this paper
• MAPKAP Kinase-2 Drives Expression of Angiogenic Factors by Tumor-Associated Macrophages in a Model of Inflammation-Induced Colon Cancer

  2021cites this paper
• A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target?

  2021cites this paper
• Corneal Collagen Cross-Linking Pretreatment Mitigates Injury-Induced Inflammation, Hemangiogenesis and Lymphangiogenesis In Vivo

  2021cites this paper
• Plasminogen activator inhibitor‐1: a potential etiological role in livedoid vasculopathy

  2020cites this paper
• Changes in the content of some components of the plasminogen activation system in the plasma of bladder cancer patients

  2020cites this paper
• Association between Five Common Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms and Colorectal Cancer Susceptibility

  2020cites this paper
• The root bark of Morus alba L. regulates tumor‐associated macrophages by blocking recruitment and M2 polarization of macrophages

  2020cites this paper
• Lupeol suppresses plasminogen activator inhibitor-1-mediated macrophage recruitment and attenuates M2 macrophage polarization.

  2020cites this paper
• Epidemiology of breast cancer, a paradigm of the "common soil" hypothesis.

  2020cites this paper
• LncRNA NKX2-1-AS1 As ceRNA Promotes Tumor Progression and Angiogenesis by Upregulating SERPINE1 Expression and Activating VEGFR-2 Signaling Pathway in Gastric Cancer

  2020cites this paper
• Serine proteases in ovarian cancer

  2020cites this paper
• Novel oral plasminogen activator inhibitor-1 inhibitor TM5275 attenuates hepatic fibrosis under metabolic syndrome via suppression of activated hepatic stellate cells in rats

  2020cites this paper
• Phosphoproteomics of Acute Cell Stressors Targeting Exercise Signaling Networks Reveal Drug Interactions Regulating Protein Secretion.

  2019cites this paper
• Circulating plasminogen activator inhibitor-1 activity: a biomarker for resectable non-small cell lung cancer?

  2019cites this paper
• The Role of the Urokinase-Type Plasminogen Activator System In Tumor Progression

  2019cites this paper
• Pancreatic stellate cells activated by mutant KRAS-mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8

  2019cites this paper
• Endothelial miR-30c suppresses tumor growth via inhibition of TGF-&bgr;–induced Serpine1

  2019cites this paper
• Unbiased global proteomic profiling of patient-derived meningiomas of all grades to identify molecular signatures of differentially expressed proteins and phosphoproteins.

  2019cites this paper
• Weighted Gene Co-Expression Network Analysis Identifies Hub Genes Associated with Occurrence and Prognosis of Oral Squamous Cell Carcinoma

  2019influential citation
• Obesity-Altered Adipose Stem Cells Promote ER+ Breast Cancer Metastasis through Estrogen Independent Pathways

  2019cites this paper
• Treatment of acute lung injury and early- and late-stage pulmonary fibrosis with combination emulsion siRNA polyplexes.

  2019cites this paper
• Plasminogen activator inhibitor-1 (PAI-1) expression in endometriosis

  2019cites this paper
• Inhibition of PAI‐1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer‐associated fibroblasts

  2019cites this paper
• Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications

  2018cites this paper
• Parameters of hemostatic potential in various stages of bladder cancer

  2018cites this paper
• The rat blood glutathione system under obesity development with the compatible consumption of the kidney bean (Phaseolus vulgaris) pods extract

  2018cites this paper
• Computational analysis of mRNA expression profiles identifies a novel triple-biomarker model as prognostic predictor of stage II and III colorectal adenocarcinoma patients

  2018cites this paper
• Aberrantly Expressed Genes and miRNAs in Slow Transit Constipation Based on RNA-Seq Analysis

  2018cites this paper
• Evaluation of PAI-1 in endometriosis using a homologous immunocompetent mouse model†

  2018cites this paper
• Plasminogen : a pleiotropic inflammatory regulator in radiation-induced wound formation and wound repair

  2018cites this paper
• High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.

  2018cites this paper
• [The urokinase-type plasminogen activator system and its role in tumor progression].

  2018cites this paper
• Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma

  2018cites this paper
• The nuclear-cytoplasmic trafficking of a chromatin-modifying and remodelling protein (KMT2C), in osteosarcoma

  2018cites this paper
• PAI1 blocks NMDA receptor-mediated effects of tissue-type plasminogen activator on cell signaling and physiology

  2018cites this paper
• Role of ZEB1 in Tumor Progression: Regulation of Cell Invasion and Senescence

  2017cites this paper
• Novel Adipocytokines: Monocyte Chemotactic Protein-1, Plasminogen Activator Inhibitor-1, Chemerin

  2017cites this paper
• Estudio del valor pronóstico de serpina e1 y su papel en el crecimiento y la diseminación metastática del carcinoma escamoso de cabeza y cuello

  2017cites this paper
• Epsilon-aminocaproic acid prevents high glucose and insulin induced-invasiveness in MDA-MB-231 breast cancer cells, modulating the plasminogen activator system

  2017cites this paper
• SERPINE2/Protease Nexin-1 in vivo multiple functions: Does the puzzle make sense?

  2017cites this paper
• Endogenous Proteases in Tumoral Progression

  2017cites this paper
• Mapping Dysregulated Metabolic Pathways in Cancer Using Chemoproteomic and Metabolomic Platforms

  2017cites this paper
• The Plasminogen Activation System

  2017cites this paper
• Role of Serine Proteases and Inhibitors in Cancer

  2017cites this paper
• Investigating Dysregulated Metabolic Pathways that Drive Cancer Pathogenicity

  2017cites this paper
• Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator

  2017cites this paper
• Platelets and cancer angiogenesis nexus

  2017influential citation
• The Function and Diagnostic Potential of Adipocyte-Derived Factors in the Tumor Microenvironment

  2017cites this paper
• uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy

  2016cites this paper
• Plasminogen activator inhibitor-1 in endometriosis

  2016cites this paper
• Role of the tumor microenvironment in tumor progression and the clinical applications (Review).

  2016cites this paper
• to hypoxia or expressing a hybrid form of HIF-1 Gene expression profiles in human cardiac cells subjected

  2016cites this paper
• Keloid‐derived, plasma/fibrin‐based skin equivalents generate de novo dermal and epidermal pathology of keloid fibrosis in a mouse model

  2016cites this paper
• Diabetes-associated dysregulated cytokines and cancer.

  2016cites this paper
• The annexin A2 system and angiogenesis

  2016cites this paper
• HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Induction of the Plasminogen Activator Inhibitor-1 Gene Expression by Mild Hypoxia Via a Hypoxia Response Element Binding the Hypoxia-Inducible Factor-1 in Rat Hepatocytes

  2016cites this paper
• Tissue Plasminogen Activator as an Antiangiogenic Agent in Experimental Laser-Induced Choroidal Neovascularization in Mice.

  2016cites this paper
• Actin and Actin-Binding Proteins.

  2016cites this paper
• Decreased expression of the plasminogen activator inhibitor type 1 is involved in degradation of extracellular matrix surrounding cervical cancer stem cells.

  2016cites this paper
• Inhibition of PAI-1 Limits Tumor Angiogenesis Regardless of Angiogenic Stimuli in Malignant Pleural Mesothelioma.

  2016cites this paper
• Role of heparin and non heparin binding serpins in coagulation and angiogenesis: A complex interplay.

  2016cites this paper
• PAI‐1, a target gene of miR‐143, regulates invasion and metastasis by upregulating MMP‐13 expression of human osteosarcoma

  2016cites this paper
• Vasculogenesis and Angiogenesis

  2016cites this paper
• Increased Umbilical Cord PAI-1 Levels in Placental Insufficiency Are Associated with Fetal Hypoxia and Angiogenesis

  2016cites this paper
• Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression

  2016cites this paper
• Soluble factors regulated by epithelial–mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment

  2015cites this paper
• Effect of Guibi-Tang, a Traditional Herbal Formula, on Retinal Neovascularization in a Mouse Model of Proliferative Retinopathy

  2015cites this paper
• Plasminogen Activator Inhibitor-1 in Cancer: Rationale and Insight for Future Therapeutic Testing.

  2015cites this paper
• Regulation of expression and functional characterization of human HIF-3α

  2015cites this paper
• Addressing Medical Device Challenges with Drug–Device Combinations

  2015cites this paper
• Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities

  2015cites this paper
• PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patients

  2015cites this paper
• Endothelial Progenitor Cells in Sprouting Angiogenesis: Proteases Pave the Way.

  2015cites this paper
• Small Molecule Inhibitors of Plasminogen Activator Inhibitor-1 Elicit Anti-Tumorigenic and Anti-Angiogenic Activity

  2015cites this paper
• α HIF-1to hypoxia or expressing a hybrid form of Gene expression profiles in human cardiac cells

  2015cites this paper
• Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer progression and liver metastasis.

  2015cites this paper